Abstract:113 Purpose: For ischaemic stroke, thrombolysis is usually be chosen to improve the clinical outcome, however the induced reperfusion injury is a potential factor of poorer recovery. Oxidative stress is one factor which can leading to cell damage and death via reactive oxygen species (ROS) thus antioxidant strategies have been used in the treatment of stroke. In this study, Fe-GA coordination polymer nanoparticles (Fe-GA NCPs) were developed for an antioxidative neuroprotector in the ischemia stroke rat model and evaluated using PET/MR imaging. Methods: The ultra-small Fe-GA NCPs were synthesized and tested by transmission electric microscope (TEM) and dynamic light scattering. Their antioxidative effect were further evaluated by the degradation of methylene blue (MB), the coloration of tetramethylbenzidine (TMB), the reduction of 1,1-diphenyl-2-picrylhydrazyl (DPPH) and the electron spin resonance (ESR) spectroscopy in vitro. To investigate the neuroprotective effects of Fe-GA NCPs nanoparticles in vivo, we induced ischemic stroke in rats and subsequently injection before reperfusion which mimicked the pathologic process in clinic. Adult Sprague-Dawley male rats were performed middle cerebral artery occlusion (MCAO), and reperfusion was performed 90 min after MCAO. Fe-GA encephalic injection was performed 1h before reperfusion under standard operation. 24 h after reperfusion, all rats underwent neurologic testing followed by neurologic function scale, 18F-FDG small animal PET (Philips), PET/MR (Siemens) scanning, 2,3,5-triphenyltetrazolium chloride (TTC) staining, hematoxylin-eosin (HE) staining and oxidative stress testing. Normal, sham operation, MCAO only, saline (NS), and edaravone were performed as control groups and evaluated as well. Results: Fe-GA NCPs were synthesized using a simple chemical process. TEM images revealed discrete and uniform 7 nm-sized nanoparticles. As proved by MB, TMB, DPPH, and ESR spectroscopy, the ultra-small Fe-GA NCPs could significantly scavenge the reactive oxygen/nitrogen species. After treated with Fe-GA NCPs, the neurological score was better than other control groups. For MCAO model, 18F-FDG PET/MR could show the low FDG uptake in the region of brain infarct and high signal in T2-weighted MRI imaging. We found that brain infarct volumes in rats treated with Fe-GA NCPs decreases significantly than other negative groups. Its therapeutic effect was even better than same concentration of edaravone which is used in clinic for same purpose. Further, TTC staining verified these in vivo imaging results. The areas of infarct lesion showed by PET/MRI were correlated with TTC staining results, suggesting PET/MRI could be effectively used for evaluation. HE staining also showed the shape and structure of infarct brain were abnormal. Finally, oxidative stress was tested for oblated brain tissue and found less ROS level in Fe-GA NCPs treated rats. Conclusions: Fe-GA CPNs exhibit an impressive antioxidative neuroprotective role in ischemia stroke, which might have the potential to be translated into clinical applications for improved treatment of patients with stroke. PET/MRI is effective and accurate method for ischemic evaluation.

Cerium Oxide Nanoparticles with Antioxidative Neurorestoration for Ischemic Stroke

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

An Ultrasmall Cu/Cu<sub>2</sub>O Nanoparticle-Based Diselenide-Bridged Nanoplatform Mediating Reactive Oxygen Species Scavenging and Neuronal Membrane Enhancement for Targeted Therapy of Ischemic Stroke

Platinum-Loaded Cerium Oxide Capable of Repairing Neuronal Homeostasis for Cerebral Ischemia-Reperfusion Injury Therapy

Antioxidant Activity and Toxicity Study of Cerium Oxide Nanoparticles Stabilized with Innovative Functional Copolymers

Nanoparticles for Targeted Delivery of Antioxidant Enzymes to the Brain after Cerebral Ischemia and Reperfusion Injury

Bioactive Ceria Nanoenzymes Target Mitochondria in Reperfusion Injury to Treat Ischemic Stroke.

Nano-integrated cascade antioxidases opsonized by albumin bypass the blood-brain barrier for treatment of ischemia-reperfusion injury

Antioxidative Neuroprotective Role Of Iron-Gallic Acid Coordination Nanoparticles And Pet/Mr Usage In An Ischemia Stroke Model

The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia.

Polydopamine-Cloaked Nanoarchitectonics of Prussian Blue Nanoparticles Promote Functional Recovery in Neonatal and Adult Ischemic Stroke Models

Antioxidant Enzyme-Mimetic Activity and Neuroprotective Effects of Cerium Oxide Nanoparticles Stabilized with Various Ratios of Citric Acid and EDTA

Targeted Therapy of Ischemic Stroke Via Crossing the Blood-Brain Barrier Using Edaravone-Loaded Multiresponsive Microgels.

Neutrophil-like Cell-Membrane-Coated Nanozyme Therapy for Ischemic Brain Damage and Long-Term Neurological Functional Recovery

Hollow Prussian Blue Nanozymes Drive Neuroprotection Against Ischemic Stroke Via Attenuating Oxidative Stress, Counteracting Inflammation, and Suppressing Cell Apoptosis

Ultrasmall Iron‐gallic Acid Coordination Polymer Nanodots with Antioxidative Neuroprotection for PET/MR Imaging‐guided Ischemia Stroke Therapy

Novel multifunctional bionanoparticles modified with sialic acid for stroke treatment

Resveratrol-Loaded Copolymer Nanoparticles with Anti-neurological Impairment, Antioxidant and Anti-inflammatory Activities against Cerebral Ischemia-Reperfusion Injury

Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: A review

Polyphenolic oligomer-derived multienzyme activity for the treatment of ischemic Stroke through ROS scavenging and blood–brain barrier restoration

Transferrin-Targeted Iridium Nanoagglomerates with Multi-Enzyme Activities for Cerebral Ischemia-Reperfusion Injury Therapy